会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CARBONYL-SUBSTITUTED TITANOCENES
    • 羰基取代茂钛
    • WO2008059068A3
    • 2008-07-31
    • PCT/EP2007062511
    • 2007-11-19
    • CHARITE UNIVERSITAETSMEDIZINUNIV BONNPROKOP ARAMSELIG ANJAGANSAEUER ANDREASFRANKE DIETER
    • PROKOP ARAMSELIG ANJAGANSAEUER ANDREASFRANKE DIETER
    • A61K31/28A61K31/7008A61P31/04A61P31/10A61P31/12A61P33/02A61P33/10A61P35/00A61P35/02C07F17/00
    • A61K31/28A61K31/7008C07F17/00A61K2300/00
    • Disclosed is a medicament containing a compound of formula (Ia) or (Ib), wherein Z is selected from among a group comprising a covalent bond, at least one at least bivalent heteroatom, a saturated, unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain, a saturated or unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain containing heteroatoms, or combinations thereof, R `1 to R `4 and R ``1 to R ``5 each independently represents H, at least one heteroatom, a saturated, unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain, a saturated or unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain containing heteroatoms, or combinations thereof, the cyclopentadienyl rings are optionally linked by means of any of the radicals R ``1 to R ``5 , R 1 and R 2 independently represent H, a heteroatom, a saturated, unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain, a saturated or unsaturated, branched, linear and/or cyclic, substituted or unsubstituted hydrocarbon chain containing heteroatoms, or combinations thereof, A`, A`` independently represent F, Cl, BR, I, and/or a physically acceptable acid radical of an organic or inorganic acid, n represents a positive integer, particularly 1, 2, 3, X = O, S, NH, NR 3 , NR 4 R 5 , wherein R 3 , R 4 , and R 5 independently have the meanings indicated for R` 1 to R` 4 , Y = a covalent bond, O, S, or NR 6 , wherein R 6 has the meaning indicated for R `1 to R `4 .
    • 含有其中Z选自共价键组成的组中的下式(Ia)或(Ib)的化合物的药物,至少一种至少二价的杂原子,饱和的,不饱和的,支链的,无支链和/或环状的,取代或未取代的烃链 在链中或提供的一个具有杂原子的,饱和或不饱和的,支链的,无支链和/或环状的,取代或未取代的烃链,或它们的组合,R `1 至R `4 ,和 [R ``1 至R ``5 各自独立地为H,至少一个杂原子,饱和的,不饱和的,支链的,无支链和/或环状的,取代或未取代的烃链, 设置有在链中杂原子,饱和或不饱和的,支链的,无支链和/或环状的,取代或未取代的 平均烃链,或它们的组合,这两个环戊二烯基环`5 是任选的任何的R ``1 至R `联,R 1 和 [R 2 各自独立地是H,杂原子,饱和的,不饱和的,支链的,无支链和/或环状的,取代或未取代的烃链,设置有在链中的杂原子的,饱和或不饱和的,支链的,无支链和 意味着/或环状的,取代或未取代的烃链或它们的组合,A`,A``,F,氯,溴,I,和/或有机或无机酸的生理学可接受的酸残基是在每一情况下彼此独立地,n是一个正整数 ,尤其是1,2,3,X = O,S,NH,NR 3 ,NR 4 - [R 5 ,其中R < SUP> 3 ,R 4 和R 5 各自独立于R 1 至R `4 ,Y =共价键,O,S,或NR 6 ,其中R 6 的 [R `1 至R `4 如上所定义。